These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30942559)

  • 21. Decision-making in drug development using a composite definition of success.
    Saint-Hilary G; Robert V; Gasparini M
    Pharm Stat; 2018 Sep; 17(5):555-569. PubMed ID: 29956453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development.
    Chen C; Anderson K; Mehrotra DV; Rubin EH; Tse A
    Contemp Clin Trials; 2018 Jan; 64():238-242. PubMed ID: 28966137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lasagna plots: a saucy alternative to spaghetti plots.
    Swihart BJ; Caffo B; James BD; Strand M; Schwartz BS; Punjabi NM
    Epidemiology; 2010 Sep; 21(5):621-5. PubMed ID: 20699681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-dimensional correlation analysis and waterfall plots for detecting positional fluctuations of spectral changes.
    Ryu SR; Noda I; Lee CH; Lee PH; Hwang H; Jung YM
    Appl Spectrosc; 2011 Apr; 65(4):359-68. PubMed ID: 21396181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iceberg plot, improving the visualisation of therapy response in oncology in the era of sequence-directed therapy.
    Lythgoe MP; Olivier T; Prasad V
    Eur J Cancer; 2021 Dec; 159():56-59. PubMed ID: 34736043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review.
    Li N; Huang HY; Wu DW; Yang ZM; Wang J; Wang JS; Wang SH; Fang H; Yu Y; Bai Y; Yan Z; Cao Y; Jiang M; Liu YF; Li KY; Xu BH; Sun Y; He J
    Lancet Oncol; 2019 Nov; 20(11):e619-e626. PubMed ID: 31674320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of tumor size response metrics to predict survival in oncology clinical trials.
    Bruno R; Mercier F; Claret L
    Clin Pharmacol Ther; 2014 Apr; 95(4):386-93. PubMed ID: 24419563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail-A Brief Report From 2018 Digestive Disease Week.
    Harris MS; Howden CW
    Gastroenterology; 2019 Apr; 156(5):1239-1242. PubMed ID: 30625298
    [No Abstract]   [Full Text] [Related]  

  • 29. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
    Younes A; Hilden P; Coiffier B; Hagenbeek A; Salles G; Wilson W; Seymour JF; Kelly K; Gribben J; Pfreunschuh M; Morschhauser F; Schoder H; Zelenetz AD; Rademaker J; Advani R; Valente N; Fortpied C; Witzig TE; Sehn LH; Engert A; Fisher RI; Zinzani PL; Federico M; Hutchings M; Bollard C; Trneny M; Elsayed YA; Tobinai K; Abramson JS; Fowler N; Goy A; Smith M; Ansell S; Kuruvilla J; Dreyling M; Thieblemont C; Little RF; Aurer I; Van Oers MHJ; Takeshita K; Gopal A; Rule S; de Vos S; Kloos I; Kaminski MS; Meignan M; Schwartz LH; Leonard JP; Schuster SJ; Seshan VE
    Ann Oncol; 2017 Jul; 28(7):1436-1447. PubMed ID: 28379322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjusting for baseline: change or percentage change?
    Kaiser L
    Stat Med; 1989 Oct; 8(10):1183-90. PubMed ID: 2682909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor burden modeling versus progression-free survival for phase II decision making.
    Kaiser LD
    Clin Cancer Res; 2013 Jan; 19(2):314-9. PubMed ID: 23172885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summarizing the incidence of adverse events using volcano plots and time intervals.
    Zink RC; Wolfinger RD; Mann G
    Clin Trials; 2013; 10(3):398-406. PubMed ID: 23690094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth.
    Johnson K; Gomez A; Burton J; White D; Chakravarty A; Schmid A; Bottino D
    Eur J Cancer; 2019 Mar; 109():196-203. PubMed ID: 30738696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.
    Pocock SJ; Clayton TC; Altman DG
    Lancet; 2002 May; 359(9318):1686-9. PubMed ID: 12020548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases.
    Goyal N; Apolo AB; Berman ED; Bagheri MH; Levine JE; Glod JW; Kaplan RN; Machado LB; Folio LR
    J Digit Imaging; 2017 Jun; 30(3):275-286. PubMed ID: 28074302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
    Wang M; Chen C; Jemielita T; Anderson J; Li XN; Hu C; Kang SP; Ibrahim N; Ebbinghaus S
    J Immunother Cancer; 2019 Feb; 7(1):39. PubMed ID: 30736858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug development and clinical trial design in pancreatico-biliary malignancies.
    Harrington J; Carter L; Basu B; Cook N
    Curr Probl Cancer; 2018; 42(1):73-94. PubMed ID: 29402439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal planning of phase II/III programs for clinical trials with multiple endpoints.
    Kieser M; Kirchner M; Dölger E; Götte H
    Pharm Stat; 2018 Sep; 17(5):437-457. PubMed ID: 29700949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.